United Therapeutics (UTHR)

United Therapeutics (UTHR) stock research: performance, analysts' price targets, earnings, revenue and margins, technicals and insider trades.

• UTHR last traded at $597.30, -0.24% on the day.
• United Therapeutics: market cap $25.68B, P/E 19.9, revenue $3.15B over the last four quarters, next earnings 2026-11-04.
• Over the past year UTHR returned 31.70%; year to date 22.59%.

Updated 2026-11-02 19:08 UTC